Intravenous ferric carboxymaltose in heart failure with iron deficiency (FAIR‐HF2 DZHK05 trial): Sex‐specific outcomes.
Saved in:
| Title: | Intravenous ferric carboxymaltose in heart failure with iron deficiency (FAIR‐HF2 DZHK05 trial): Sex‐specific outcomes. |
|---|---|
| Authors: | Karakas, Mahir1,2 (AUTHOR) m.karakas@uke.de, Friede, Tim3,4 (AUTHOR), Butler, Javed5,6 (AUTHOR), Talha, Khawaja M.7 (AUTHOR), Placzek, Marius3,4 (AUTHOR), Asendorf, Thomas3,4 (AUTHOR), Diek, Monika8 (AUTHOR), Nosko, Anna1 (AUTHOR), Stas, Adriane4,9 (AUTHOR), Kluge, Stefan1 (AUTHOR), Jarczak, Dominik1 (AUTHOR), DeHeer, Geraldine1 (AUTHOR), Rybczynski, Meike2,10 (AUTHOR), Bayes‐Genis, Antoni11 (AUTHOR), Böhm, Michael12 (AUTHOR), Coats, Andrew J.S.13 (AUTHOR), Edelmann, Frank14,15 (AUTHOR), Filippatos, Gerasimos16 (AUTHOR), Hasenfuß, Gerd4,17 (AUTHOR), Haverkamp, Wilhelm8 (AUTHOR) |
| Source: | European Journal of Heart Failure. Nov2025, Vol. 27 Issue 11, p2328-2342. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
